Peptide Companion
Peptide Companion
blend
Recovery & Repair
Vial: 80 mg

How is KLOW (80 mg Blend) dosed and mixed?

KLOW (80 mg Blend) is a peptide blend research reference in the Recovery & Repair category for a 80 mg vial. The reference mixing guide adds 3 mL of bacteriostatic water, giving a concentration of 26.7 mg/mL. The full reference schedule, supplies and cited studies are listed below; it is reference information, not a recommendation.

By Vincent Ceniceros · Published · Last updated

KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound repair, angiogenesis, and tissue repair. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle repair. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling. GHK-Cu supports collagen synthesis, wound repair, and tissue regeneration. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Detailed protocol below.

Dosing Schedule
WeekDaily Dose (per component)Units (per injection) (mL)
Weeks 1–2TB-500: 250 mcg \BPC-157: 250 mcg \
Weeks 3–4TB-500: 500 mcg \BPC-157: 500 mcg \
Weeks 5–8TB-500: 750 mcg \BPC-157: 750 mcg \
Weeks 9–12 (Maintenance)TB-500: 500 mcg \BPC-157: 500 mcg \
Mixing & Quick Reference
Bacteriostatic water
3 mL
Concentration
26.7 mg/mL
  • •Reconstitute: Add 3.0 mL bacteriostatic water → ~ 26.7 mg/mL total concentration.
  • •Component concentrations: TB-500, BPC-157, KPV each at ~3.33 mg/mL; GHK-Cu at ~16.7 mg/mL.
  • •Easy measuring: At 26.7 mg/mL total, 1 unit = 0.01 mL ≈ 267 mcg total peptide on a U-100 insulin syringe.
  • •Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
Supplies Needed
  • •Peptide Vials (KLOW, 80 mg each): - 8 weeks ≈ 3 vials - 12 weeks ≈ 4 vials - 16 weeks ≈ 5 vials
  • •Insulin Syringes (U-100): - Per week: 7 syringes (1/day) - 8 weeks: 56 syringes - 12 weeks: 84 syringes - 16 weeks: 112 syringes
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. - 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle - 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles - 16 weeks (5 vials): 15 mL → 2 × 10 mL bottles
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day. - Per week: 14 swabs (2/day) - 8 weeks: 112 swabs → recommend 2 × 100-count boxes - 12 weeks: 168 swabs → recommend 2 × 100-count boxes - 16 weeks: 224 swabs → recommend 3 × 100-count boxes
How It Works

KLOW combines four peptides with complementary mechanisms of action:

- TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure. Preclinical studies demonstrate accelerated wound repair, reduced inflammation, and tissue regeneration. - BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle repair through enhanced angiogenesis and growth factor modulation. Animal studies show favorable tissue repair outcomes. - KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects. - GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound repair, and modulates gene expression related to tissue remodeling.

References and original studies

  • PubMed

    Thymosin beta 4 accelerates wound healing (Philp et al., 1999)

    View original study

  • PubMed

    Thymosin β4 promotes dermal healing in preclinical models and clinical trials

    View original study

  • PMC

    Emerging use of BPC-157 in orthopaedic sports medicine: systematic review

    View original study

  • PMC

    Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 in rats and dogs

    View original study

  • PMC

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

    View original study

  • PMC

    Orally targeted delivery of tripeptide KPV via HA-functionalized nanoparticles alleviates ulcerative colitis

    View original study

  • PMC

    Regenerative and protective actions of the GHK-Cu peptide in light of new gene data

    View original study

  • PMC

    GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration

    View original study

  • Sigma-Aldrich

    Handling and storage guidelines for peptides and proteins

    View source

  • CDC

    Vaccine administration: subcutaneous injection technique guidelines

    View source

  • CDC

    Vaccine administration best practices (aspiration not recommended for SC injections)

    View source

  • NCBI Bookshelf

    Chapter 18: Administration of parenteral medications (injection technique)

    View original study

  • PubMed

    Thymosin β4: a multi-functional regenerative peptide (basic properties and clinical applications)

    View original study

  • PMC

    The potential of GHK as an anti-aging peptide

    View original study

About the author

Vincent Ceniceros

Vincent Ceniceros created Peptide Companion and publishes its Dosage Library. Each guide summarizes a reference protocol and links to the studies and sources it draws on.

Published · Last updated

Related guides

Work out the mixing math for any vial with the peptide reconstitution calculator, or browse the full Dosage Library.

Educational content adapted from peptidedosages.com. Not medical advice.